Sun Pharma ends deal for taking over Taro Pharmaceutical
- IPL spot-fixing case: Actor Vindoo Dara Singh arrested
- IPL 2013: Final No.5 for MS Dhoni-led Chennai Super Kings
- Pune Warriors withdraw from IPL, 'disgusted' by BCCI's attitude
- IPL spot fixing: Accused Sreesanth claims innocence
- Li Keqiang visits TCS, Cyrus P Mistry says China important for growth of Tata Group
Sun Pharmaceutical Industries Ltd ended its agreement to takeover Israeli unit Taro Pharmaceutical Industries Ltd.
The companies decided that ending the deal was in the best interest of their shareholders, Sun Pharma and Taro said in a joint filing.
Sun Pharma had last offered $39.50 per share, or about $571 million, for the one-third stake it did not already own in Taro, seemingly winning over the Israeli company's board following a long battle to gain full control of the U.S. listed drugmaker.
Taro shares closed at $50.55 on Thursday on the New York Stock Exchange.
Sun Pharma shares closed at 746.10 rupees on Friday on the National Stock Exchange.
- Fixing probe now reaches Bollywood, son of Dara Singh held
- BCCI cashes Pune guarantee, Sahara walks out of IPL
- 'Sree spent Rs 1.95L on clothes, bought friend BlackBerry'
- Delhi firm with MoD as client is linked to Pak cyberattacks
- After Infosys, iGATE sacks Phaneesh Murthy for sexual misconduct
- 2 weeks after harassment, Haryana schoolgirls return, cops in tow